Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Cellular and Molecular Life Sciences : CMLS
|
January 22, 2010
Sulindac sulfide suppresses 5-lipoxygenase at clinically relevant concentrations
Svenja D Steinbrink, Carlo Pergola, Ulrike Bühring, et al.
Cancer Research
|
August 2, 2014
5-Lipoxygenase is a candidate target for therapeutic management of stem cell-like cells in acute myeloid leukemia
Jessica Roos, Claudia Oancea, Maria Heinssmann, et al.
Antioxidants & Redox Signaling
|
November 12, 2013
Electrophilic fatty acid species inhibit 5-lipoxygenase and attenuate sepsis-induced pulmonary inflammation
Khader Awwad, Svenja D Steinbrink, Timo Frömel, et al.
Frontiers in Pharmacology
|
December 6, 2021
Structural Modifications Yield Novel Insights Into the Intriguing Pharmacodynamic Potential of Anti-inflammatory Nitro-Fatty Acids
Nadine Hellmuth, Camilla Brat, Omar Awad, et al.
Frontiers in Pharmacology
|
October 5, 2020
The Emerging Therapeutic Potential of Nitro Fatty Acids and Other Michael Acceptor-Containing Drugs for the Treatment of Inflammation and Cancer
Matthias Piesche, Jessica Roos, Benjamin Kühn, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
September 7, 2018
Sphingosine-1-phosphate (S1P) induces potent anti-inflammatory effects in vitro and in vivo by S1P receptor 4-mediated suppression of 5-lipoxygenase activity
Jasmin Fettel, Benjamin Kühn, Nathalie A Guillen, et al.
Biochemical Pharmacology
|
June 18, 2018
Anti-inflammatory nitro-fatty acids suppress tumor growth by triggering mitochondrial dysfunction and activation of the intrinsic apoptotic pathway in colorectal cancer cells
Benjamin Kühn, Camilla Brat, Jasmin Fettel, et al.
Pharmacology & Therapeutics
|
November 10, 2015
Regulation of tumorigenic Wnt signaling by cyclooxygenase-2, 5-lipoxygenase and their pharmacological inhibitors: A basis for novel drugs targeting cancer cells?
Jessica Roos, Sabine Grösch, Oliver Werz, et al.
Frontiers in Pharmacology
|
April 6, 2019
Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γ
Tamara Göbel, Olaf Diehl, Jan Heering, et al.
The Journal of Clinical Investigation
|
July 25, 2017
Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males
Simona Pace, Carlo Pergola, Friederike Dehm, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Cellular and Molecular Life Sciences : CMLS
|
January 22, 2010
Sulindac sulfide suppresses 5-lipoxygenase at clinically relevant concentrations
Svenja D Steinbrink, Carlo Pergola, Ulrike Bühring, et al.
Cancer Research
|
August 2, 2014
5-Lipoxygenase is a candidate target for therapeutic management of stem cell-like cells in acute myeloid leukemia
Jessica Roos, Claudia Oancea, Maria Heinssmann, et al.
Antioxidants & Redox Signaling
|
November 12, 2013
Electrophilic fatty acid species inhibit 5-lipoxygenase and attenuate sepsis-induced pulmonary inflammation
Khader Awwad, Svenja D Steinbrink, Timo Frömel, et al.
Frontiers in Pharmacology
|
December 6, 2021
Structural Modifications Yield Novel Insights Into the Intriguing Pharmacodynamic Potential of Anti-inflammatory Nitro-Fatty Acids
Nadine Hellmuth, Camilla Brat, Omar Awad, et al.
Frontiers in Pharmacology
|
October 5, 2020
The Emerging Therapeutic Potential of Nitro Fatty Acids and Other Michael Acceptor-Containing Drugs for the Treatment of Inflammation and Cancer
Matthias Piesche, Jessica Roos, Benjamin Kühn, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
September 7, 2018
Sphingosine-1-phosphate (S1P) induces potent anti-inflammatory effects in vitro and in vivo by S1P receptor 4-mediated suppression of 5-lipoxygenase activity
Jasmin Fettel, Benjamin Kühn, Nathalie A Guillen, et al.
Biochemical Pharmacology
|
June 18, 2018
Anti-inflammatory nitro-fatty acids suppress tumor growth by triggering mitochondrial dysfunction and activation of the intrinsic apoptotic pathway in colorectal cancer cells
Benjamin Kühn, Camilla Brat, Jasmin Fettel, et al.
Pharmacology & Therapeutics
|
November 10, 2015
Regulation of tumorigenic Wnt signaling by cyclooxygenase-2, 5-lipoxygenase and their pharmacological inhibitors: A basis for novel drugs targeting cancer cells?
Jessica Roos, Sabine Grösch, Oliver Werz, et al.
Frontiers in Pharmacology
|
April 6, 2019
Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γ
Tamara Göbel, Olaf Diehl, Jan Heering, et al.
The Journal of Clinical Investigation
|
July 25, 2017
Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males
Simona Pace, Carlo Pergola, Friederike Dehm, et al.
Page
of 5